These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines. Na HN; Dubuisson O; Hegde V; Nam JH; Dhurandhar NV Biochimie; 2016 May; 124():3-10. PubMed ID: 25450249 [TBL] [Abstract][Full Text] [Related]
3. E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. Dhurandhar EJ; Krishnapuram R; Hegde V; Dubuisson O; Tao R; Dong XC; Ye J; Dhurandhar NV PLoS One; 2012; 7(10):e47813. PubMed ID: 23110104 [TBL] [Abstract][Full Text] [Related]
4. Doxycycline-regulated 3T3-L1 preadipocyte cell line with inducible, stable expression of adenoviral E4orf1 gene: a cell model to study insulin-independent glucose disposal. Krishnapuram R; Dhurandhar EJ; Dubuisson O; Hegde V; Dhurandhar NV PLoS One; 2013; 8(3):e60651. PubMed ID: 23544159 [TBL] [Abstract][Full Text] [Related]
6. Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes. Yoon IS; Park S; Kim RH; Ko HL; Nam JH Int J Obes (Lond); 2017 Oct; 41(10):1601-1605. PubMed ID: 28607454 [TBL] [Abstract][Full Text] [Related]
7. An adenovirus-derived protein: A novel candidate for anti-diabetic drug development. Hegde V; Na HN; Dubuisson O; Burke SJ; Collier JJ; Burk D; Mendoza T; Dhurandhar NV Biochimie; 2016 Feb; 121():140-50. PubMed ID: 26700141 [TBL] [Abstract][Full Text] [Related]
14. Template to improve glycemic control without reducing adiposity or dietary fat. Krishnapuram R; Dhurandhar EJ; Dubuisson O; Kirk-Ballard H; Bajpeyi S; Butte N; Sothern MS; Larsen-Meyer E; Chalew S; Bennett B; Gupta AK; Greenway FL; Johnson W; Brashear M; Reinhart G; Rankinen T; Bouchard C; Cefalu WT; Ye J; Javier R; Zuberi A; Dhurandhar NV Am J Physiol Endocrinol Metab; 2011 May; 300(5):E779-89. PubMed ID: 21266671 [TBL] [Abstract][Full Text] [Related]
15. Reducing endogenous insulin is linked with protection against hepatic steatosis in mice. Akheruzzaman M; Hegde V; Shin AC; Dhurandhar NV Nutr Diabetes; 2020 Apr; 10(1):11. PubMed ID: 32286259 [TBL] [Abstract][Full Text] [Related]
16. What we know and what we need to know about adenovirus 36-induced obesity. Kim J; Na H; Kim JA; Nam JH Int J Obes (Lond); 2020 Jun; 44(6):1197-1209. PubMed ID: 31942033 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated in vitro delivery of E4orf1 to preadipocytes is a clinically relevant delivery system to improve glucose uptake. Feizy Z; Peddibhotla S; Khan S; Hegde V; Wang S; Dhurandhar NV Int J Obes (Lond); 2020 Jul; 44(7):1607-1616. PubMed ID: 31965070 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus E4-ORF1 Dysregulates Epidermal Growth Factor and Insulin/Insulin-Like Growth Factor Receptors To Mediate Constitutive Myc Expression. Kong K; Kumar M; Taruishi M; Javier RT J Virol; 2015 Nov; 89(21):10774-85. PubMed ID: 26269183 [TBL] [Abstract][Full Text] [Related]
19. Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway. Jiao Y; Liang X; Hou J; Aisa Y; Wu H; Zhang Z; Nuermaimaiti N; Zhao Y; Jiang S; Guan Y Lipids Health Dis; 2019 Mar; 18(1):70. PubMed ID: 30902099 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the adipogenic protein E4orf1 from adenovirus 36 through an in silico approach. Gutiérrez A; Ferreira GM; Machuca J; Venthur H; Feres F; Hirata MH; Hirata RDC; Cerda A J Mol Model; 2020 Sep; 26(10):285. PubMed ID: 32978703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]